<a href="https://laohu8.com/S/AVR.AU">Anteris Technologies</a> Signs Amended Services Agreement with Switchback Medical
Anteris Technologies Global Corp. has entered into a significant agreement with Switchback Medical, LLC, under a First Amended and Restated Master Services Agreement (A&R MSA) signed on July 28, 2025. This agreement appoints Switchback to deliver development and manufacturing services, including engineering and testing, for Anteris Technologies. The contract outlines that Switchback will perform these services in accordance with specified purchase orders and quality standards. A notable element of this agreement is the limited, exclusive license granted to Switchback to use certain Anteris Technologies' intellectual property, strictly for manufacturing purposes during the agreement's term. The A&R MSA is set to expire on March 31, 2028, with provisions for automatic one-year renewals unless either party opts out 180 days before the renewal date. This strategic partnership is expected to enhance Anteris Technologies' operational capabilities in product development and manufacturing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anteris Technologies Global Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-027864), on July 29, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.